Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 503

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 503
---
--|:----------------------------------------|:--|-----------:|:--|:--|:--|:--------|:--|-----------:|:--|:--|:--|:--------|:--|-----------:|:--|:--|:--|:--------|:--|-----------:|:--|:--|
| Net loss                                            | ​ | ​ | ​                                       | $ |     -1,625 | ​ | ​ | ​ | ​       | $ |     -1,692 | ​ | ​ | ​ | ​       | $ |     -2,064 | ​ | ​ | ​ | ​       | $ |     -2,149 | ​ | ​ |
| Denominator                                         | ​ | ​ | ​                                       | ​ |          ​ | ​ | ​ | ​ | ​       | ​ |          ​ | ​ | ​ | ​ | ​       | ​ |          ​ | ​ | ​ | ​ | ​       | ​ |          ​ | ​ | ​ |
| Basic and diluted weighted average unitsoutstanding | ​ | ​ | ​                                       | ​ | 95,555,554 | ​ | ​ | ​ | ​       | ​ | 16,666,666 | ​ | ​ | ​ | ​       | ​ | 82,546,600 | ​ | ​ | ​ | ​       | ​ | 16,666,666 | ​ | ​ |
| Basic and diluted net loss per member unit          | ​ | ​ | ​                                       | $ |      -0.02 | ​ | ​ | ​ | ​       | $ |      -0.10 | ​ | ​ | ​ | ​       | $ |      -0.03 | ​ | ​ | ​ | ​       | $ |      -0.13 | ​ | ​ |

Recently Issued Accounting Pronouncements In December 2023, the FASB issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . The standard requires entities to disclose additional categories about federal, state and foreign income taxes in the effective tax rate reconciliation as well as provide

F-60

TABLE OF CONTENTS

#### LIMINATUS PHARMA, LLC

### NOTES TO CONDENSED FINANCIAL STATEMENTS

#### SEPTEMBER 30, 2024
<div align='center'>**(Unaudited)**</div>

annual income taxes paid disaggregated by federal